Genetisch modifizierte regulatorische T-Zellen: Therapiekonzepte und ihr regulatorischer Rahmen

Adoptive T‑cell therapies are emerging tools to combat various human diseases. CAR‑T cells are approved and marketed as last line therapeutics in advanced B‑cell lymphomas and leukemias. TCR-engineered T cells are being evaluated in clinical trials for a variety of hematological and solid tumors. Ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebe, Attila, Anliker, Brigitte, Rau, Juliane, Renner, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647973/
https://www.ncbi.nlm.nih.gov/pubmed/33067665
http://dx.doi.org/10.1007/s00103-020-03230-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647973/
https://www.ncbi.nlm.nih.gov/pubmed/33067665
http://dx.doi.org/10.1007/s00103-020-03230-8

Ejemplares similares